|
1
|
Ritter J and Bielack SS: Osteosarcoma. Ann
Oncol. 21 (Suppl 7):vii320–vii325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smeland S, Bielack SS, Whelan J, Bernstein
M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC,
Anninga J, et al: Survival and prognosis with osteosarcoma:
Outcomes in more than 2000 patients in the EURAMOS-1 (European and
American Osteosarcoma Study) cohort. Eur J Cancer. 109:36–50. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Botter SM, Neri D and Fuchs B: Recent
advances in osteosarcoma. Curr Opin Pharmacol. 16:15–23. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Meazza C and Scanagatta P: Metastatic
osteosarcoma: A challenging multidisciplinary treatment. Expert Rev
Anticancer Ther. 16:543–556. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: Metazoan MicroRNAs. Cell.
173:20–51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jones KB, Salah Z, Del Mare S, Galasso M,
Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, et
al: miRNA signatures associate with pathogenesis and progression of
osteosarcoma. Cancer Res. 72:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Delsin LEA, Roberto GM, Fedatto PF, Engel
EE, Scrideli CA, Tone LG and Brassesco MS: Downregulated
adhesion-associated microRNAs as prognostic predictors in childhood
osteosarcoma. Pathol Oncol Res. 25:11–20. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial- mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guarino M: Epithelial-mesenchymal
transition and tumour invasion. Int J Biochem Cell Biol.
39:2153–2160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liao TT and Yang MH: Revisiting
epithelial-mesenchymal transition in cancer metastasis: The
connection between epithelial plasticity and stemness. Mol Oncol.
11:792–804. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yeung KT and Yang J:
Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol.
11:28–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vandewalle C, Van Roy F and Berx G: The
role of the ZEB family of transcription factors in development and
disease. Cell Mol Life Sci. 66:773–787. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Xu L, Li A and Han X: The roles
of ZEB1 in tumorigenic progression and epigenetic modifications.
Biomed Pharmacother. 110:400–408. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen A, Zhang Y, Yang H, Xu R and Huang G:
Overexpression of ZEB1 relates to metastasis and invasion in
osteosarcoma. J Surg Oncol. 105:830–834. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang R, Zhang C, Liu G, Gu R and Wu H:
MicroRNA-126 inhibits proliferation, migration, invasion and EMT in
osteosarcoma by targeting ZEB1. J Cell Biochem. 118:3765–3774.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yi L, Liu M and Tang Z: MicroRNA-130a
inhibits growth and metastasis of osteosarcoma cells by directly
targeting ZEB1. Mol Med Rep. 16:3606–3612. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deng Y, Luan F, Zeng L, Zhang Y and Ma K:
MiR-429 suppresses the progression and metastasis of osteosarcoma
by targeting ZEB1. EXCLI J. 16:618–627. 2017.PubMed/NCBI
|
|
22
|
Strong AL, Jiang Q, Zhang Q, Zheng S, Boue
SM, Elliott S, Burow ME, Bunnell BA and Wang G: Design, synthesis,
and osteogenic activity of daidzein analogs on human mesenchymal
stem cells. ACS Med Chem Lett. 5:143–148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou Y, Jiang R, An L, Wang H, Cheng S,
Qiong S and Weng Y: Benzo[a]pyrene impedes self-renewal and
differentiation of mesenchymal stem cells and influences fracture
healing. Sci Total Environ. 587-588:305–315. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-(-Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lytle JR, Yario TA and Steitz JA: Target
mRNAs are repressed as efficiently by microRNA-binding sites in the
5′ UTR as in the 3′ UTR. Proc Natl Acad Sci USA. 104:9667–9672.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang H, Tang M, Ou L, Hou M, Feng T, Huang
YE, Jin Y, Zhang H and Zuo G: Biological analysis of cancer
specific microRNAs on function modeling in osteosarcoma. Sci Rep.
7:53822017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Senthil Kumar KJ, Gokila Vani M, Hsieh HW,
Lin CC, Liao JW, Chueh PJ and Wang SY: MicroRNA-708 activation by
glucocorticoid receptor agonists regulate breast cancer
tumorigenesis and metastasis via downregulation of NF-κB signaling.
Carcinogenesis. 40:335–348. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin KT, Yeh YM, Chuang CM, Yang SY, Chang
JW, Sun SP, Wang YS, Chao KC and Wang LH: Glucocorticoids mediate
induction of microRNA-708 to suppress ovarian cancer metastasis
through targeting Rap1B. Nat Commun. 6:59172015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ryu S, McDonnell K, Choi H, Gao D, Hahn M,
Joshi N, Park SM, Catena R, Do Y, Brazin J, et al: Suppression of
miRNA-708 by polycomb group promotes metastases by calcium-induced
cell migration. Cancer Cell. 23:63–76. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saini S, Yamamura S, Majid S, Shahryari V,
Hirata H, Tanaka Y and Dahiya R: MicroRNA-708 induces apoptosis and
suppresses tumorigenicity in renal cancer cells. Cancer Res.
71:6208–6219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Song T, Zhang X, Zhang L, Dong J, Cai W,
Gao J and Hong B: miR-708 promotes the development of bladder
carcinoma via direct repression of Caspase-2. J Cancer Res Clin
Oncol. 139:1189–1198. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lei SL, Zhao H, Yao HL, Chen Y, Lei ZD,
Liu KJ and Yang Q: Regulatory roles of microRNA-708 and microRNA-31
in proliferation, apoptosis and invasion of colorectal cancer
cells. Oncol Lett. 8:1768–1774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Piepoli A, Tavano F, Copetti M, Mazza T,
Palumbo O, Panza A, di Mola FF, Pazienza V, Mazzoccoli G, Biscaglia
G, et al: MiRNA expression profiles identify drivers in colorectal
and pancreatic cancers. PLoS One. 7:e336632012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sui C, Liu D, Hu Y and Zhang L:
MicroRNA-708-5p affects proliferation and invasion of osteosarcoma
cells by targeting URGCP. Exp Ther Med. 17:2235–2241.
2019.PubMed/NCBI
|
|
37
|
Gambera S, Abarrategi A, Rodríguez-Milla
MA, Mulero F, Menéndez ST, Rodriguez R, Navarro S and García-Castro
J: Role of activator protein-1 complex on the phenotype of human
osteosarcomas generated from mesenchymal stem cells. Stem Cells.
36:1487–1500. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yoon SO, Park SJ, Yun CH and Chung AS:
Roles of matrix metalloproteinases in tumor metastasis and
angiogenesis. J Biochem Mol Biol. 36:128–137. 2003.PubMed/NCBI
|
|
39
|
Song XF, Wang QH and Huo R: Effects of
microRNA-708 on epithelial-mesenchymal transition, cell
proliferation and apoptosis in melanoma cells by targeting LEF1
through the Wnt signaling pathway. Pathol Oncol Res. 25:377–389.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yan H, Zhang B, Fang C and Chen L: miR-340
alleviates chemoresistance of osteosarcoma cells by targeting ZEB1.
Anticancer Drugs. 29:440–448. 2018. View Article : Google Scholar : PubMed/NCBI
|
